Empros Pharma

Empros Pharma has developed a revolutionary drug (EMP16). The primary mechanism of action of EMP16 is to delay the normal digestion and absorption process of food at the end of the small intestine. Based on proprietary advanced drug delivery technology, EMP16 is designed to optimize its effects throughout the gastrointestinal system.